Message framing for smoking cessation: the interaction of risk perceptions and gender - PubMed (original) (raw)
Randomized Controlled Trial
Message framing for smoking cessation: the interaction of risk perceptions and gender
Benjamin A Toll et al. Nicotine Tob Res. 2008 Jan.
Abstract
Because quitting smoking is clearly linked to preventing health problems such as lung cancer, research on health message framing based on prospect theory suggests that gain-framed messages (i.e., emphasizing the benefits of quitting smoking) would be more persuasive in promoting cessation than loss-framed messages (i.e., emphasizing the costs of continuing to smoke). However, because women tend to anticipate greater perceived risk from quitting smoking than men, this may affect how receptive they are to specific message framing interventions. Data from 249 participants (129 females, 120 males) in a clinical trial of message framing for smoking cessation with bupropion were used to examine how gender differences in perceptions of the risks associated with quitting influence the effects of framed interventions using number of days to smoking relapse as the criterion. Perceived risk of quitting scores were dichotomized using a median split for the entire sample. Women reported a higher perceived risk of cessation than men. Participants who anticipated high risks associated with quitting smoking reported fewer days to relapse. Further, females in the gain-framed condition who reported low perceived risks of cessation had a greater number of days to relapse, as opposed to females in the loss-framed condition. These findings suggest that message framing interventions for smoking cessation should consider the influence of gender and risk perceptions associated with quitting on the effectiveness of framed interventions.
Figures
Figure 1
Days to first cigarette as a function of perceived risk for smoking cessation (high vs. low) and message condition (gain- vs. loss-framed) for females and males.
Similar articles
- Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial.
Toll BA, O'Malley SS, Katulak NA, Wu R, Dubin JA, Latimer A, Meandzija B, George TP, Jatlow P, Cooney JL, Salovey P. Toll BA, et al. Psychol Addict Behav. 2007 Dec;21(4):534-44. doi: 10.1037/0893-164X.21.4.534. Psychol Addict Behav. 2007. PMID: 18072836 Free PMC article. Clinical Trial. - Positive Facts, Negative Stories: Message Framing as a Moderator of Narrative Persuasion in Antismoking Communication.
Ma Z, Nan X. Ma Z, et al. Health Commun. 2019 Nov;34(12):1454-1460. doi: 10.1080/10410236.2018.1499702. Epub 2018 Jul 24. Health Commun. 2019. PMID: 30040484 - Health message framing effects on attitudes, intentions, and behavior: a meta-analytic review.
Gallagher KM, Updegraff JA. Gallagher KM, et al. Ann Behav Med. 2012 Feb;43(1):101-16. doi: 10.1007/s12160-011-9308-7. Ann Behav Med. 2012. PMID: 21993844 Review. - Shaping perceptions to motivate healthy behavior: the role of message framing.
Rothman AJ, Salovey P. Rothman AJ, et al. Psychol Bull. 1997 Jan;121(1):3-19. doi: 10.1037/0033-2909.121.1.3. Psychol Bull. 1997. PMID: 9000890 Review.
Cited by
- Can social media encourage diabetes self-screenings? A randomized controlled trial with Indonesian Facebook users.
Fritz M, Grimm M, Weber I, Yom-Tov E, Praditya B. Fritz M, et al. NPJ Digit Med. 2024 Sep 13;7(1):245. doi: 10.1038/s41746-024-01246-x. NPJ Digit Med. 2024. PMID: 39271847 Free PMC article. - Efficacy of Digital Outreach Strategies for Collecting Smoking Data: Pragmatic Randomized Trial.
Kearney LE, Jansen E, Kathuria H, Steiling K, Jones KC, Walkey A, Cordella N. Kearney LE, et al. JMIR Form Res. 2024 Feb 9;8:e50465. doi: 10.2196/50465. JMIR Form Res. 2024. PMID: 38335012 Free PMC article. - Antidepressants for smoking cessation.
Hajizadeh A, Howes S, Theodoulou A, Klemperer E, Hartmann-Boyce J, Livingstone-Banks J, Lindson N. Hajizadeh A, et al. Cochrane Database Syst Rev. 2023 May 24;5(5):CD000031. doi: 10.1002/14651858.CD000031.pub6. Cochrane Database Syst Rev. 2023. PMID: 37230961 Free PMC article. Review. - Message Framing for Men? Gender Moderated Effects of Culturally Targeted Message Framing on Colorectal Cancer Screening Receptivity among African Americans.
Lucas T, Rogers CR, Aspiras O, Manning M, Dawadi A, Thompson HS. Lucas T, et al. Psychol Men Masc. 2023 Apr;24(2):103-112. doi: 10.1037/men0000418. Epub 2023 Jan 19. Psychol Men Masc. 2023. PMID: 37193560 Free PMC article. - A Multimethod Evaluation of Tobacco Treatment Trial Recruitment Messages for Current Smokers Recently Diagnosed With Cancer: Pilot Factorial Randomized Controlled Trial.
Neil JM, Senecal C, Ballini L, Chang Y, Goshe B, Flores E, Ostroff JS, Park ER. Neil JM, et al. JMIR Cancer. 2022 Aug 24;8(3):e37526. doi: 10.2196/37526. JMIR Cancer. 2022. PMID: 36001378 Free PMC article.
References
- Apanovitch AM, McCarthy D, Salovey P. Using message framing to motivate HIV testing among low-income, ethnic minority women. Health Psychology. 2003;22:60–67. - PubMed
- Brandon TH, Copeland AL, Saper ZL. Programmed therapeutic messages as a smoking treatment adjunct: Reducing the impact of negative affect. Health Psychology. 1995;14:41–47. - PubMed
- Brown RA, Burgess SA, Sales SD, Whiteley JA, Evans DM, Miller IW. Reliability and validity of a smoking timeline followback interview. Psychology of Addictive Behaviors. 1998;12:101–112.
- Detweiler JB, Bedell BT, Salovey P, Pronin E, Rothman AJ. Message framing and sunscreen use: Gain-framed messages motivate beach goers. Health Psychology. 1999;18:189–196. - PubMed
- Kiene SM, Barta WD, Zelenski JM, Cothran DL. Why are you bringing up condoms now? The effect of message content on framing effects of condom use messages. Health Psychology. 2005;24:321–326. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P50 DA013334-05/DA/NIDA NIH HHS/United States
- P50 AA015632/AA/NIAAA NIH HHS/United States
- R01 CA068427/CA/NCI NIH HHS/United States
- P50 DA013334/DA/NIDA NIH HHS/United States
- AA014715/AA/NIAAA NIH HHS/United States
- K12 DA000167-15/DA/NIDA NIH HHS/United States
- P50 AA015632-06/AA/NIAAA NIH HHS/United States
- K12 DA000167/DA/NIDA NIH HHS/United States
- DA13334/DA/NIDA NIH HHS/United States
- DA00167/DA/NIDA NIH HHS/United States
- K05 AA014715-05/AA/NIAAA NIH HHS/United States
- AA15632/AA/NIAAA NIH HHS/United States
- K05 AA014715/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical